Skip to main content
Livermore
Livermore
ZHEN

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Inmune Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+4 vs. Q4 2023
Shares held
2.74M
+447.1K (+19.5%) vs. Q4 2023
Total value
$32.2M
+$6.37M (+24.7%) vs. Q4 2023
New holders
11
17 more added
Sold out
7
11 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 52 institutions
Q1 2021: 33 institutionsQ2 2021: 41 institutionsQ3 2021: 41 institutionsQ4 2021: 43 institutionsQ1 2022: 34 institutionsQ2 2022: 36 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 35 institutionsQ2 2023: 34 institutionsQ3 2023: 37 institutionsQ4 2023: 48 institutionsQ1 2024: 52 institutionsQ2 2024: 57 institutionsQ3 2024: 67 institutionsQ4 2024: 73 institutionsQ1 2025: 82 institutionsQ2 2025: 79 institutionsQ3 2025: 73 institutionsQ4 2025: 74 institutionsQ1 2026: 82 institutionsQ2 2026: 82 institutions
Value heldQ1 2024: $32.2M
Q1 2021: $15.5MQ2 2021: $30.6MQ3 2021: $37.7MQ4 2021: $25.4MQ1 2022: $19.3MQ2 2022: $17.7MQ3 2022: $11.9MQ4 2022: $10.4MQ1 2023: $11.7MQ2 2023: $18.2MQ3 2023: $14.5MQ4 2023: $25.8MQ1 2024: $32.2MQ2 2024: $40.3MQ3 2024: $28.8MQ4 2024: $29.5MQ1 2025: $48.1MQ2 2025: $12.7MQ3 2025: $9.64MQ4 2025: $7.93MQ1 2026: $6.09MQ2 2026: $7.08M
Institutions holding INMB and their total value by quarter
QuarterHoldersValue
Q2 202682$7.08M
Q1 202682$6.09M
Q4 202574$7.93M
Q3 202573$9.64M
Q2 202579$12.7M
Q1 202582$48.1M
Q4 202473$29.5M
Q3 202467$28.8M
Q2 202457$40.3M
Q1 202452$32.2M
Q4 202348$25.8M
Q3 202337$14.5M
Q2 202334$18.2M
Q1 202335$11.7M
Q4 202234$10.4M
Q3 202233$11.9M
Q2 202236$17.7M
Q1 202234$19.3M
Q4 202143$25.4M
Q3 202141$37.7M
Q2 202141$30.6M
Q1 202133$15.5M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Inmune Bio, Inc.; share changes are against Q4 2023.

Institutions holding INMB in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc541,329$6.36M0.00%00.0%Unchanged
BlackRock Inc.240,166$2.82M0.00%−17,763−6.9%Reduced
MAI Capital Management181,410$2.13M0.02%+83,398+85.1%Added
Rhenman & Partners Asset Management AB178,284$2.09M0.20%00.0%Unchanged
Geode Capital Management, LLC170,802$2.01M0.00%+762+0.4%Added
Millennium Management LLC159,192$1.87M0.00%+134,988+557.7%Added
Susquehanna International Group, LLP154,834$1.82M0.00%+110,998+253.2%Added
Janney Montgomery Scott LLC140,911$1.66M0.00%−22,648−13.8%Reduced
Deutsche Bank AG109,848$1.29M0.00%00.0%Unchanged
Goldman Sachs Group Inc87,605$1.03M0.00%+87,605New
Royal Bank of Canada82,736$973.0K0.00%+24,945+43.2%Added
Jane Street Group, LLC73,970$869.1K0.00%+30,836+71.5%Added
Citigroup Inc48,044$564.5K0.00%+12,144+33.8%Added
State Street Corp45,063$529.5K0.00%00.0%Unchanged
Qube Research & Technologies Ltd44,165$518.9K0.00%+14,728+50.0%Added
Man Group plc40,549$476.5K0.00%+24,895+159.0%Added
UBS Group AG38,300$450.0K0.00%−4,915−11.4%Reduced
Westside Investment Management, Inc.34,390$404.1K0.10%−7,475−17.9%Reduced
Laird Norton Trust Company, LLC31,500$370.1K0.05%00.0%Unchanged
Fermata Advisors, LLC31,451$369.5K0.08%+2,025+6.9%Added
HRT Financial LP29,898$351.0K0.00%+29,898New
Morgan Stanley27,479$322.9K0.00%+14,676+114.6%Added
Marshall Wace, LLP26,825$315.2K0.00%+26,825New
Bank of New York Mellon Corp26,089$306.5K0.00%−7,311−21.9%Reduced
Northern Trust Corp20,417$239.9K0.00%−4,652−18.6%Reduced
Balyasny Asset Management LLC20,047$235.6K0.00%−3,211−13.8%Reduced
Brevan Howard Capital Management LP16,422$193.0K0.02%+16,422New
Marathon Trading Investment Management LLC14,500$170.4K0.07%+14,500New
Squarepoint Ops LLC13,441$157.9K0.00%+13,441New
Point72 Asia (Singapore) Pte. Ltd.13,438$157.9K0.04%+13,438New
Advisor Group Holdings, Inc.12,270$144.2K0.00%+1,570+14.7%Added
Y-Intercept (Hong Kong) Ltd11,059$129.9K0.01%+11,059New
Laurion Capital Management LP11,011$129.4K0.00%00.0%Unchanged
Financial Advocates Investment Management10,500$123.4K0.01%−2,000−16.0%Reduced
GWM Advisors LLC10,475$123.1K0.00%+50+0.5%Added
Beacon Pointe Advisors, LLC10,368$121.8K0.00%00.0%Unchanged
LPL Financial LLC10,022$117.8K0.00%−75−0.7%Reduced
Bank of America Corp8,768$103.0K0.00%−5,343−37.9%Reduced
Cubist Systematic Strategies, LLC4,782$56.2K0.00%+4,782New
Tower Research Capital LLC (TRC)2,255$26.5K0.00%+721+47.0%Added
Leonteq Securities AG1,600$18.8K0.00%00.0%Unchanged
Valley National Advisers Inc1,000$11.0K0.00%00.0%Unchanged
Continuum Advisory, LLC1,000$10.8K0.00%+1,000New
FMR LLC585$6.87K0.00%+500+588.2%Added
Clearstead Advisors, LLC490$4.86K0.00%+70+16.7%Added
Federation des caisses Desjardins du Quebec400$4.70K0.00%00.0%Unchanged
NBC Securities, Inc.270$3.00K0.00%00.0%Unchanged
IFP Advisors, Inc184$2.16K0.00%00.0%Unchanged
Wells Fargo & Company147$1.73K0.00%+2+1.4%Added
FNY Investment Advisers, LLC100$1.00K0.00%00.0%Unchanged
Citadel Advisors LLC30$3530.00%−33,821−99.9%Reduced
Macquarie Group Ltd444$50.00%+444New
Quadrant Capital Group LLC0$00.00%−60,000−100.0%Sold out
683 Capital Management, LLC0$00.00%−19,253−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−18,220−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−14,948−100.0%Sold out
JPMorgan Chase & Co0$00.00%−3,479−100.0%Sold out
Group One Trading, L.P.0$00.00%−2,375−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,090−100.0%Sold out